Matthew Plavan
2016 - Arcadia Biosciences
In 2016, Matthew Plavan earned a total compensation of $749.4K as Chief Financial Officer at Arcadia Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $28,583 |
|---|---|
| Option Awards | $640,077 |
| Salary | $80,771 |
| Total | $749,431 |
Plavan received $640.1K in option awards, accounting for 85% of the total pay in 2016.
Plavan also received $28.6K in non-equity incentive plan and $80.8K in salary.
Rankings
In 2016, Matthew Plavan's compensation ranked 9,577th out of 14,075 executives tracked by ExecPay. In other words, Plavan earned more than 32.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,577 out of 14,075 | 32nd |
Division Agriculture, Forestry, And Fishing | 16 out of 48 | 67th |
Major group Agricultural Production Crops | 7 out of 31 | 77th |
Source: SEC filing on May 17, 2018.
Plavan's colleagues
We found eight more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2016.
2016
Rajendra Ketkar
Arcadia Biosciences
Chief Executive Officer
2016
Wendy Neal
Arcadia Biosciences
Chief Legal Officer
2016
Vic Knauf
Arcadia Biosciences
Chief Scientific Officer
2016
Roger Salameh
Arcadia Biosciences
Chief Executive Officer
2016
Eric Rey
Arcadia Biosciences
Chief Executive Officer
2016
Zhongjin Lu
Arcadia Biosciences
Vice President, Product Development
2016
Thomas O'Neil
Arcadia Biosciences
Chief Financial Officer
2016
Mark Wong
Arcadia Biosciences
Chief Executive Officer
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019